Loozen Charlotte S, Oor Jelmer E, van Ramshorst Bert, van Santvoort Hjalmar C, Boerma Djamila
Department of Surgery, St Antonius Hospital, Koekoekslaan 1, 3430 VB, Nieuwegein, The Netherlands.
Surg Endosc. 2017 Feb;31(2):504-515. doi: 10.1007/s00464-016-5011-x. Epub 2016 Jun 17.
In medical practice, the tendency to remove an inflamed gallbladder is deeply rooted. Cholecystectomy, however, is associated with relatively high complication rates, and therefore the decision whether or not to perform surgery should be well considered. For some patients, the surgical risk-benefit profile may favour conservative treatment. The objective of this study was to examine the short- and long-term outcome of conservative treatment of patients with acute calculous cholecystitis.
A systematic search of MEDLINE, Embase and Cochrane Library databases was performed. Prospective studies reporting on the success rate of conservative treatment (i.e. non-invasive treatment) of acute cholecystitis during index admission were included, as well as prospective and retrospective studies reporting on the recurrence rate of gallstone-related disease during long-term follow-up (i.e. ≥12 months) after initial non-surgical management. Study selection was undertaken independently by two reviewers using predefined criteria. The risk of bias was assessed. The pooled success and mortality rate during index admission and the pooled recurrence rate of gallstone-related disease during long-term follow-up were calculated using a random-effects model.
A total of 1841 patients were included in 10 randomized controlled trials and 14 non-randomized studies. Conservative treatment during index admission was successful in 87 % of patients with acute calculous cholecystitis and in 96 % of patients with mild disease. In the long term, 22 % of the patients developed recurrent gallstone-related disease. Pooled analysis showed a success rate of 86 % (95 % CI 0.8-0.9), a mortality rate of 0.5 % (95 % CI 0.001-0.009) and a recurrence rate of 20 % (95 % CI 0.1-0.3).
Conservative treatment of acute calculous cholecystitis during index admission seems feasible and safe, especially in patients with mild disease. During long-term follow-up, less than a quarter of the patients appear to develop recurrent gallstone-related disease, although this outcome is based on limited data.
在医学实践中,切除发炎胆囊的倾向根深蒂固。然而,胆囊切除术的并发症发生率相对较高,因此是否进行手术的决定应慎重考虑。对于一些患者,手术的风险效益比可能有利于保守治疗。本研究的目的是探讨急性结石性胆囊炎患者保守治疗的短期和长期结果。
对MEDLINE、Embase和Cochrane图书馆数据库进行系统检索。纳入报告首次住院期间急性胆囊炎保守治疗(即非侵入性治疗)成功率的前瞻性研究,以及报告初始非手术治疗后长期随访(即≥12个月)期间胆结石相关疾病复发率的前瞻性和回顾性研究。由两名 reviewers 使用预定义标准独立进行研究选择。评估偏倚风险。使用随机效应模型计算首次住院期间的合并成功率和死亡率以及长期随访期间胆结石相关疾病的合并复发率。
10项随机对照试验和14项非随机研究共纳入1841例患者。首次住院期间,87%的急性结石性胆囊炎患者和96%的轻症患者保守治疗成功。从长期来看,22%的患者出现了复发性胆结石相关疾病。汇总分析显示成功率为86%(95%CI 0.8 - 0.9),死亡率为0.5%(95%CI 0.001 - 0.009),复发率为20%(95%CI 0.1 - 0.3)。
首次住院期间对急性结石性胆囊炎进行保守治疗似乎是可行和安全的,尤其是对于轻症患者。在长期随访中,不到四分之一的患者似乎会出现复发性胆结石相关疾病,尽管这一结果基于有限的数据。